MEF2D and hepatocellular carcinoma: In some HCC cells, Lysine-specific demethylase 1 A decreases MEF2D methylation by interacting with it, demethylated MEF2D binds to the PD-L1 promoter and activates PD-L1 expression, thus promoting immune inhibitory activity [206].